# Cue Biopharma, Inc.: Form 8-K, filed Apr 14, 2025

- Company: [Cue Biopharma, Inc.](/companies/cue.md) (CIK 1645460)
- Form: 8-K
- Filed: 2025-04-14
- Accepted by EDGAR: Apr 14, 2025, 21:03 ET
- Period: 2025-04-10
- Accession: 0001193125-25-080277
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645460/000119312525080277/d894534d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645460/000119312525080277/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645460/000119312525080277/d894534d8k.htm

Filed Apr 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-080277. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.